Impact of HLA-A2 status on ipilimumab efficacy and safety: Pooled data from four phase II trials in advanced melanoma Meeting Abstract


Authors: Wolchok, J. D.; Weber, J. S.; Hamid, O.; Lebbé, C.; Maio, M.; Schadendorf, D.; de Pril, V.; Ibrahim, R.; Hoos, A.; O'Day, S. J.
Abstract Title: Impact of HLA-A2 status on ipilimumab efficacy and safety: Pooled data from four phase II trials in advanced melanoma
Meeting Title: 25th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer
Journal Title: Journal of Immunotherapy
Volume: 33
Issue: 8
Meeting Dates: 2010 Oct 2-4
Meeting Location: Washington, D.C.
ISSN: 1524-9557
Publisher: Lippincott Williams & Wilkins  
Date Published: 2010-10-01
Start Page: 913
Language: English
ACCESSION: ISI:000282131800179
PROVIDER: wos
DOI: 10.1097/CJI.0b013e3181f1e08d
Notes: --- - Meeting Abstract - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok